Letter in Reply
- PMID: 37267197
- DOI: 10.1097/ADM.0000000000001119
Letter in Reply
Conflict of interest statement
The authors report no conflicts of interest.
Comment on
-
Self-reported Past Experiences With Naltrexone and Attitudes Toward Daily Adherence Among High-utilization Patients With Alcohol Use Disorder.J Addict Med. 2023 May-Jun 01;17(3):371-372. doi: 10.1097/ADM.0000000000001120. Epub 2023 Jan 17. J Addict Med. 2023. PMID: 37267196 No abstract available.
References
-
- Terasaki D. Self-reported past experiences with naltrexone and attitudes toward daily adherence among high utilization patients with alcohol use disorder. J Addict Med . 2022. In press.
-
- Gregory C, Chorny Y, McLeod SL, et al. First-line medications for the outpatient treatment of alcohol use disorder: a systematic review of perceived barriers. J Addict Med . 2022;16(4):e210–e218.
-
- Murphy CE 4th, Wang RC, Montoy JC, et al. Effect of extended-release naltrexone on alcohol consumption: a systematic review and meta-analysis. Addiction . 2022;117(2):271–281.
Publication types
LinkOut - more resources
Full Text Sources
